XML 42 R31.htm IDEA: XBRL DOCUMENT v3.19.1
11. Segment Information Segment Reporting (Tables)
3 Months Ended
Mar. 31, 2019
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment [Table Text Block] Information regarding industry segments for the three months ended March 31, 2019 and 2018 is as follows (in millions):
 
 
Life
Science
 
Clinical
Diagnostics
 
Other
Operations
 
 
 
 
 
 
 
Segment net sales 
2019
$
215.7

 
$
334.1

 
$
4.2

 
2018
$
197.8

 
$
350.8

 
$
2.9

 
 
 
 
 
 
 
Segment net profit (loss)
2019
$
22.8

 
$
30.9

 
$
(0.1
)
 
2018
$
3.3

 
$
36.6

 
$


Information regarding industry segments at March 31, 2019, and December 31, 2018 is as follows (in millions):

 
 
Life
Science
 
Clinical
Diagnostics
 
Other
Operations
 
 
 
 
 
 
 
Segment assets
March 31, 2019
$
503.7

 
$
1,123.8

 
$
7.4

 
December 31, 2018
$
450.2

 
$
949.0

 
$
5.9


Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block] The following reconciles total segment profit to consolidated income before taxes (in millions):
 
Three Months Ended
 
March 31,
 
2019
 
2018
Total segment profit
$
53.6

 
$
39.9

Foreign currency exchange losses, net
(1.3
)
 
(1.3
)
Net corporate operating, interest and other expense not allocated to segments
(2.9
)
 
(1.9
)
Change in fair market value of equity securities
1,059.2

 
815.9

Other income (expense), net
18.7

 
11.1

Consolidated income before income taxes
$
1,127.3

 
$
863.7

Reconciliation of Assets from Segment to Consolidated [Table Text Block] The following reconciles total segment assets to consolidated total assets (in millions):
 
March 31, 2019
 
December 31, 2018
Total segment assets
$
1,634.9

 
$
1,405.1

Cash and other current assets
1,049.5

 
1,047.2

Property, plant and equipment, net, excluding
 
 
 
  segment specific gross machinery and equipment
71.8

 
79.9

Goodwill, net
230.5

 
219.8

Other long-term assets
3,876.2

 
2,859.1

Total assets
$
6,862.9

 
$
5,611.1